Ox-LDL Upregulates CRP Expression Through the IGF2 Pathway in THP-1 Macrophages
C-reactive protein (CRP) is an acute-phase reactant protein that not only plays a predictive role in determining atherogenesis risk but also represents an active participant in atherogenesis onset and progression. Moreover, an increasing number of studies have reported that oxidized low-density lipoprotein (Ox-LDL) plays a significant role in the initiation and progression of atherosclerosis. However, the effect and underlying mechanism of Ox-LDL on CRP expression remains unclear. THP-1 macrophages were treated with 0, 25, 50, or 100 μg/mL of Ox-LDL for 48 h, or 50 μg/mL of Ox-LDL for 0, 12, 24, and 48 h, respectively. Messenger RNA (mRNA) and protein levels were measured by real-time quantitative PCR and Western blot analysis, respectively. We found that Ox-LDL markedly increased insulin-like growth factor 2 (IGF2) and CRP mRNA and protein levels in a dose- and time-dependent manner in THP-1 macrophages. Treatment with Ox-LDL increased CRP protein expression, and this effect was completely abolished by siRNA-mediated silencing of IGF2 in THP-1 macrophages. Moreover, treatment with pcDNA3.1-IGF2 significantly enhanced CRP protein expression in Ox-LDL-stimulated THP-1 macrophages. CRP expression is upregulated by Ox-LDL through the IGF2 pathway in THP-1 macrophages.
KEY WORDSOx-LDL IGF2 CRP THP-1 macrophages
The authors gratefully acknowledge financial support from the National Natural Sciences Foundation of China (grant nos. 81271905 and 81301489).
Conflict of Interest
The authors declare that they have no competing interests.
- 8.Hunt, K.J., A. Lukanova, S. Rinaldi, E. Lundin, T. Norat, R. Palmqvist, P. Stattin, E. Riboli, G. Hallmans, and R. Kaaks. 2006. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Annals of Epidemiology 16: 563–571.PubMedCrossRefGoogle Scholar
- 9.Van Bunderen, C.C., I.C. van Nieuwpoort, N.M. van Schoor, D.J. Deeg, P. Lips, and M.L. Drent. 2010. The association of serum Insulin-like growth factor-I with mortality, cardiovascular disease and cancer in the elderly: a population-based study. Journal of Clinical Endocrinology and Metabolism 95: 4616–4624.PubMedCrossRefGoogle Scholar
- 15.Sukhanov, S., Y. Higashi, S.Y. Shai, C. Vaughn, J. Mohler, Y. Li, Y.H. Song, J. Titterington, and P. Delafontaine. 2007. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2684–2690.PubMedCrossRefGoogle Scholar
- 17.Doumatey, A.P., G. Chen, F.T. Ayele, J. Zhou, M. Erdos, D. Shriner, H. Huang, J. Adeleye, W. Balogun, O. Fasanmade, T. Johnson, J. Oli, G. Okafor, A. Amoah, B.A. Eghan, K. Agyenim-Boateng, J. Acheampong, C. Adebamowo, N.P. Gerry, M.F. Christman, A. Adeyemo, and C.N. Rotimi. 2012. C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans. Human Molecular Genetics 21(13): 3063–3072.PubMedCentralPubMedCrossRefGoogle Scholar
- 19.Fox, E.R., E.J. Benjamin, D.F. Sarpong, C.N. Rotimi, J.G. Wilson, M.W. Steffes, G. Chen, A. Adeyemo, J.K. Taylor, T.E. Samdarshi, and H.A. Taylor Jr. 2008. Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). American Journal of Cardiology 102: 835–841.PubMedCentralPubMedCrossRefGoogle Scholar
- 22.Hu, Y.W., X. Ma, J.L. Huang, X.R. Mao, J.Y. Yang, J.Y. Zhao, S.F. Li, Y.R. Qiu, J. Yang, L. Zheng, and Q. Wang. 2013. Dihydrocapsaicin attenuates plaque formation through a PPARc/LXRa pathway in apoE−/− mice fed a high-fat/high-cholesterol diet. PLoS ONE 8(6): e66876.PubMedCentralPubMedCrossRefGoogle Scholar
- 23.Hu, Y.W., P. Zhang, J.Y. Yang, J.L. Huang, X. Ma, S.F. Li, J.Y. Zhao, Y.R. Hu, Y.C. Wang, J.J. Gao, Y.H. Sha, L. Zheng, and Q. Wang. 2014. Nur77 Decreases atherosclerosis progression in apoE−/− mice fed a high-fat/high-cholesterol diet. PLoS ONE 9(1): e87313.PubMedCentralPubMedCrossRefGoogle Scholar
- 24.Hu, Y.W., Yang, J.Y., Ma, X., Chen, Z.P., Hu, Y.R., Zhao, J.Y., Li, S.F., Qiu, Y.R., Lu, J.B., Wang, Y.C., Gao, J.J., Sha, Y.H., Zheng, L., Wang, Q. 2014. A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis and inflammatory reactions. Journal of Lipid Research Feb 3Google Scholar
- 25.Ruidavets, J.B., G. Luc, E. Machez, A.L. Genoux, F. Kee, D. Arveiler, P. Morange, J.V. Woodside, P. Amouyel, A. Evans, P. Ducimetière, A. Bingham, J. Ferrières, and B. Perret. 2011. Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis 218: 464–469.PubMedCrossRefGoogle Scholar
- 26.Hu, Y.W., X. Ma, X.X. Li, X.H. Liu, J. Xiao, Z.C. Mo, J. Xiang, D.F. Liao, and C.K. Tang. 2009. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 204: e35–e43.PubMedCrossRefGoogle Scholar
- 30.Danesh, J., J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys, and V. Gudnason. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350: 1387–1397.PubMedCrossRefGoogle Scholar
- 37.Sukhanov, S., Y. Higashi, S.Y. Shai, C. Vaughn, J. Mohler, Y. Li, Y.H. Song, J. Titterington, and P. Delafontaine. 2007. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2684–2690.PubMedCrossRefGoogle Scholar